Ectdmodule1usa1
Levetiracetam Tablet, Extended Release
Product Images NDC 13668-272
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 13668-272). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Ectdmodule1usa2
Ectdmodule1usa3
This text provides information about immediate-release Levetiracetam dosage, with a daily intake of 1000-2000 mg.*
Ectdmodule1usa4
Ectdmodule1usa5
Ectdmodule1usa6
Ectdmodule1usa7
Levetirac Exte 500 500t
Levetirac Exte 750 500t
This is a description for Levetiracetam extended-release tablets containing 750 mg of levetiracetam, USP. The tablets should be stored at a temperature range of 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). They should be dispensed in a securely closed, light-resistant container. The usual dosage information can be found in the accompanying prescribing information. The tablets are manufactured by Torrent Pharmaceuticals Ltd. in India and distributed by Torrent Pharma Inc. in Levittown, PA. Each container includes 500 tablets for distribution. The label also includes NDC information for identification and proper handling instructions for pharmacists.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
